Vascular Robot Articles & Analysis
21 news found
Recently, the Ministry of Industry and Information Technology, the National Health Commission and other 17 departments jointly issued the "robot" application action implementation plan to encourage the development of surgery, auxiliary examination, auxiliary rounds, intensive care, rehabilitation and other medical robot products, "robot The ...
End of study brings Robocath closer to commercializing R-One in China in 2023 149 patients enrolled over six months in four Chinese centers Results of first vascular robotics study on this scale in China will be published in March 2023 Robocath, a company that designs, develops and commercializes innovative robotic platforms for the ...
ByRobocath
100% clinical success rate: zero complications linked to robot up to 30 days post-procedure >95% technical success rate 84.5% average reduction in physician radiation exposure Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, today presents the results of ...
ByRobocath
Corindus, A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced today the opening of its new headquarters at 275 Grove Street in Newton, Mass. ...
The company is a key supplier to the world’s leading Medical Device Manufacturers specializing in Orthopedics, Spine, Robotics, Ophthalmology, Vascular, ENT, General Surgical Equipment, and Diagnostics. ...
The company is a key supplier to the world’s leading Medical Device Manufacturers specializing in Orthopedics, Spine, Robotics, Ophthalmology, Vascular, ENT, General Surgical Equipment, and Diagnostics. ...
Prior to that, he held leadership roles in clinical and regulatory affairs at Conformal Medical, Corindus Vascular Robotics, ZOLL Medical Corporation, Edwards Lifesciences, and Pavad Medical. ...
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, announces today that it has concluded its ‘R-Evolution’ clinical study. ...
ByRobocath
The company is a key supplier to the world’s leading Medical Device Manufacturers specializing in Orthopedics, Spine, Robotics, Ophthalmology, Vascular, ENT, General Surgical Equipment, and Diagnostics. ...
The company is a key supplier to the world’s leading Medical Device Manufacturers specializing in Orthopedics, Spine, Robotics, Ophthalmology, Vascular, ENT, General Surgical Equipment, and Diagnostics. ...
Robocath, a company that designs, develops and commercializes cardiovascular robotic platforms for the treatment of vascular diseases, today announces the successful completion of first five robotic coronary angioplasties in Belgium. ...
ByRobocath
Corindus, A Siemens Healthineers Company and one of the leading developers of precision vascular robotics, announced today it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021, earning the No. 5 spot in the robotics category. ...
Corindus, A Siemens Healthineers Company and one of the leading developers of precision vascular robotics, announced today it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021, earning the No. 5 spot in the robotics category. ...
Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces the successful completion of the first remote robotic-assisted coronary angioplasty in Europe. ...
ByRobocath
Corindus, A Siemens Healthineers Company and one of the leading developers of precision vascular robotics, announced today the global launch of a new set of automated robotic movements in the technIQ Series designed for the CorPath GRX System. ...
She will use her extensive knowledge of imaging systems to analyze strategic opportunities for promoting interoperability of equipments used in cath labs, in particular compatibility with R-One™, the first robotic platform, as well as future robotic generations. Philippe Bencteux, President and founder of Robocath, said: “I’m honored that a ...
ByRobocath
Corindus, a Siemens Healthineers company and leading developer of precision vascular robotics, announced today that Circulation: Cardiovascular Interventions has published clinical results from a comparative study between robotic percutaneous coronary intervention (PCI) and manual PCI. ...
Startup presenting companies: Acarix Access Vascular Activ Surgical AiM Medical Robotics Alertgy Alucent Biomedical Articulate Labs Aspect Biosystems Auctus Surgical Augmedics Bardy Diagnostics Inc Biolinq Biorez Bridge Medical Devices Briteseed Canary Health Technologies Canary Medical CardioThrive Carmell Therapeutics CathWorks CellMax ...
Corindus, a Siemens Healthineers company and a leading developer of precision vascular robotics, announced today it has completed the first multi-city, transcontinental percutaneous coronary intervention (PCI) simulations in the United States over three network connection types – 5G wireless, dedicated fiber, and commercial public internet networks. ...
Corindus, a Siemens Healthineers Company and leading developer of precision vascular robotics, announced today its CorPath® GRX System was used to complete the first-in-human robotic-assisted neurovascular intervention. ...